— Why it moved
Why CRIS Stock Spiked and Faded Today — November 4, 2026
Curis pushed out a quick premarket run on zero new filings, giving active traders a brief ten-minute window before dumping below the alert price.
What moved CRIS stock
Curis is a clinical-stage biotech developing cancer drugs. The company had no fresh headlines on Wednesday. The only recent catalyst was an SEC proxy filing two days prior proposing a reverse stock split to maintain its Nasdaq listing.
The mechanics
A tight float of roughly two million shares got slammed with over 162 million shares of trading volume. Gapping up nearly 85 percent without a real driver is standard low-float momentum mechanics, not fundamental buying.
CRIS by the numbers
The alert window
The alert hit at $1.39 at 7:15 AM ET during premarket action. Traders had to digest a tiny dip to $1.34 before the ticker surged to $2.03 just ten minutes later. That offered a clean 46.1 percent exit window, with 94 total minutes spent above the alert line.
How CRIS's move ended
Buying interest dissolved long before the session finished. CRIS drifted steadily downward to close at $1.13, down 18.7 percent from the alert level. With an impending reverse split vote and zero revenue momentum, bagholders took the brunt of the fade.
The tell: Premarket volume spikes tied to reverse split proxies almost always crash once liquidity migrates to late chasers.